119 related articles for article (PubMed ID: 14988020)
1. Activation of the WT1 tumor suppressor gene promoter by Pea3.
Discenza MT; Vaz D; Hassell JA; Pelletier J
FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
4. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
[TBL] [Abstract][Full Text] [Related]
5. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
[TBL] [Abstract][Full Text] [Related]
6. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
Lee TH; Pelletier J
Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
10. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
11. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
12. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
13. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
[TBL] [Abstract][Full Text] [Related]
14. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Lynch CC; Crawford HC; Matrisian LM; McDonnell S
Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
Loeb DM; Evron E; Patel CB; Sharma PM; Niranjan B; Buluwela L; Weitzman SA; Korz D; Sukumar S
Cancer Res; 2001 Feb; 61(3):921-5. PubMed ID: 11221883
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
18. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells.
Chen JH; Vercamer C; Li Z; Paulin D; Vandenbunder B; Stehelin D
Oncogene; 1996 Oct; 13(8):1667-75. PubMed ID: 8895512
[TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
20. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
